PDB Short entry for 1W5V HEADER HYDROLASE/HYDROLASE INHIBITOR 10-AUG-04 1W5V TITLE HIV-1 PROTEASE IN COMPLEX WITH FLUORO SUBSTITUTED DIOL-BASED C2- TITLE 2 SYMMETRIC INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: HIV-1 PROTEASE; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: RESIDUES 58-167; COMPND 5 EC: 3.4.23.16; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HUMAN IMMUNODEFICIENCY VIRUS; SOURCE 3 ORGANISM_COMMON: HIV-1; SOURCE 4 ORGANISM_TAXID: 12721; SOURCE 5 VARIANT: BH10; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS HYDROLASE/HYDROLASE INHIBITOR, HYDROLASE, DIMER, PROTEIN-INHIBITOR KEYWDS 2 COMPLEX, HYDROLASE-HYDROLASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR J.LINDBERG,D.PYRING,S.LOEWGREN,A.ROSENQUIST,G.ZUCCARELLO, AUTHOR 2 I.KVARNSTROEM,H.ZHANG,L.VRANG,B.CLAESSON,A.HALLBERG,B.SAMUELSSON, AUTHOR 3 T.UNGE REVDAT 4 17-JAN-18 1W5V 1 REMARK REVDAT 3 24-FEB-09 1W5V 1 VERSN REVDAT 2 22-DEC-04 1W5V 1 JRNL REVDAT 1 01-DEC-04 1W5V 0 JRNL AUTH J.LINDBERG,D.PYRING,S.LOEWGREN,A.ROSENQUIST,G.ZUCCARELLO, JRNL AUTH 2 I.KVARNSTROEM,H.ZHANG,L.VRANG,B.CLAESSON,A.HALLBERG, JRNL AUTH 3 B.SAMUELSSON,T.UNGE JRNL TITL SYMMETRIC FLUORO-SUBSTITUTED DIOL-BASED HIV PROTEASE JRNL TITL 2 INHIBITORS. ORTHO-FLUORINATED AND META-FLUORINATED JRNL TITL 3 P1/P1'-BENZYLOXY SIDE GROUPS SIGNIFICANTLY IMPROVE THE JRNL TITL 4 ANTIVIRAL ACTIVITY AND PRESERVE BINDING EFFICACY JRNL REF EUR.J.BIOCHEM. V. 271 4594 2004 JRNL REFN ISSN 0014-2956 JRNL PMID 15560801 JRNL DOI 10.1111/J.1432-1033.2004.04431.X REMARK 2 REMARK 2 RESOLUTION. 1.80 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.1 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.80 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 24.45 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 1220995.600 REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 94.3 REMARK 3 NUMBER OF REFLECTIONS : 21211 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.189 REMARK 3 FREE R VALUE : 0.215 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 1080 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.007 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.80 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.91 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 90.50 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 3160 REMARK 3 BIN R VALUE (WORKING SET) : 0.2180 REMARK 3 BIN FREE R VALUE : 0.2340 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.90 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 164 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.018 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1516 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 50 REMARK 3 SOLVENT ATOMS : 118 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 12.60 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 21.90 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.00000 REMARK 3 B22 (A**2) : 0.00000 REMARK 3 B33 (A**2) : 0.00000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.20 REMARK 3 ESD FROM SIGMAA (A) : 0.11 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.22 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.10 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.005 REMARK 3 BOND ANGLES (DEGREES) : 1.200 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 25.20 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.700 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.310 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 1.980 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 2.490 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 3.790 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.33 REMARK 3 BSOL : 33.43 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : BED.PAR REMARK 3 PARAMETER FILE 3 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 4 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : BED.TOP REMARK 3 TOPOLOGY FILE 3 : NULL REMARK 3 TOPOLOGY FILE 4 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1W5V COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 10-AUG-04. REMARK 100 THE DEPOSITION ID IS D_1290020735. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : 278.0 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : NULL REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : MAX II REMARK 200 BEAMLINE : I711 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.976 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : NULL REMARK 200 DETECTOR MANUFACTURER : NULL REMARK 200 INTENSITY-INTEGRATION SOFTWARE : NULL REMARK 200 DATA SCALING SOFTWARE : NULL REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 21224 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.800 REMARK 200 RESOLUTION RANGE LOW (A) : 25.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 95.0 REMARK 200 DATA REDUNDANCY : 2.000 REMARK 200 R MERGE (I) : 0.03000 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.80 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.90 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 49.65 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.44 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: NULL REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X+1/2,Y+1/2,-Z REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 29.26600 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 43.06050 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 29.26600 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 43.06050 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ALA A -10 REMARK 465 ASP A -9 REMARK 465 ARG A -8 REMARK 465 GLN A -7 REMARK 465 GLY A -6 REMARK 465 THR A -5 REMARK 465 VAL A -4 REMARK 465 SER A -3 REMARK 465 PHE A -2 REMARK 465 ASN A -1 REMARK 465 PHE A 0 REMARK 465 ALA B -10 REMARK 465 ASP B -9 REMARK 465 ARG B -8 REMARK 465 GLN B -7 REMARK 465 GLY B -6 REMARK 465 THR B -5 REMARK 465 VAL B -4 REMARK 465 SER B -3 REMARK 465 PHE B -2 REMARK 465 ASN B -1 REMARK 465 PHE B 0 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLU B 35 128.24 -39.85 REMARK 500 REMARK 500 REMARK: NULL REMARK 700 REMARK 700 SHEET REMARK 700 DETERMINATION METHOD: DSSP REMARK 700 THE SHEETS PRESENTED AS "AB" IN EACH CHAIN ON SHEET RECORDS REMARK 700 BELOW IS ACTUALLY AN 7-STRANDED BARREL THIS IS REPRESENTED BY REMARK 700 A 8-STRANDED SHEET IN WHICH THE FIRST AND LAST STRANDS REMARK 700 ARE IDENTICAL. REMARK 700 THE SHEETS PRESENTED AS "BA" IN EACH CHAIN ON SHEET RECORDS REMARK 700 BELOW IS ACTUALLY AN 7-STRANDED BARREL THIS IS REPRESENTED BY REMARK 700 A 8-STRANDED SHEET IN WHICH THE FIRST AND LAST STRANDS REMARK 700 ARE IDENTICAL. REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE BE3 A1100 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1AJV RELATED DB: PDB REMARK 900 HIV-1 PROTEASE IN COMPLEX WITH THE CYCLIC SULFAMIDE INHIBITOR AHA006 REMARK 900 RELATED ID: 1AJX RELATED DB: PDB REMARK 900 HIV-1 PROTEASE IN COMPLEX WITH THE CYCLIC UREA INHIBITOR AHA001 REMARK 900 RELATED ID: 1AXA RELATED DB: PDB REMARK 900 ACTIVE-SITE MOBILITY IN HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 REMARK 900 PROTEASE AS DEMONSTRATED BY CRYSTAL STRUCTURE OF A28S MUTANT REMARK 900 RELATED ID: 1BQM RELATED DB: PDB REMARK 900 HIV-1 RT/HBY 097 REMARK 900 RELATED ID: 1BQN RELATED DB: PDB REMARK 900 TYR 188 LEU HIV-1 RT/HBY 097 REMARK 900 RELATED ID: 1D4H RELATED DB: PDB REMARK 900 HIV-1 PROTEASE IN COMPLEX WITH THE INHIBITOR BEA435 REMARK 900 RELATED ID: 1D4I RELATED DB: PDB REMARK 900 HIV-1 PROTEASE IN COMPLEX WITH THE INHIBITOR BEA425 REMARK 900 RELATED ID: 1D4J RELATED DB: PDB REMARK 900 HIV-1 PROTEASE IN COMPLEX WITH THE INHIBITOR MSL370 REMARK 900 RELATED ID: 1DLO RELATED DB: PDB REMARK 900 HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 REMARK 900 RELATED ID: 1DW6 RELATED DB: PDB REMARK 900 STRUCTURAL AND KINETIC ANALYSIS OF DRUG RESISTANT MUTANTS OF HIV-1 REMARK 900 PROTEASE REMARK 900 RELATED ID: 1EBK RELATED DB: PDB REMARK 900 STRUCTURAL AND KINETIC ANALYSIS OF DRUG RESISTANT MUTANTS OF HIV-1 REMARK 900 PROTEASE REMARK 900 RELATED ID: 1EBW RELATED DB: PDB REMARK 900 HIV-1 PROTEASE IN COMPLEX WITH THE INHIBITOR BEA322 REMARK 900 RELATED ID: 1EBY RELATED DB: PDB REMARK 900 HIV-1 PROTEASE IN COMPLEX WITH THE INHIBITOR BEA369 REMARK 900 RELATED ID: 1EBZ RELATED DB: PDB REMARK 900 HIV-1 PROTEASE IN COMPLEX WITH THE INHIBITOR BEA388 REMARK 900 RELATED ID: 1EC0 RELATED DB: PDB REMARK 900 HIV-1 PROTEASE IN COMPLEX WITH THE INHIBITOR BEA403 REMARK 900 RELATED ID: 1EC1 RELATED DB: PDB REMARK 900 HIV-1 PROTEASE IN COMPLEX WITH THE INHIBITOR BEA409 REMARK 900 RELATED ID: 1EC2 RELATED DB: PDB REMARK 900 HIV-1 PROTEASE IN COMPLEX WITH THE INHIBITOR BEA428 REMARK 900 RELATED ID: 1EC3 RELATED DB: PDB REMARK 900 HIV-1 PROTEASE IN COMPLEX WITH THE INHIBITOR MSA367 REMARK 900 RELATED ID: 1EET RELATED DB: PDB REMARK 900 HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH THE INHIBITOR MSC204 REMARK 900 RELATED ID: 1HBV RELATED DB: PDB REMARK 900 HIV-1 PROTEASE COMPLEXED WITH SB203238 REMARK 900 RELATED ID: 1HEF RELATED DB: PDB REMARK 900 HIV-1 PROTEASE COMPLEXED WITH SKF 108738 (HEF) REMARK 900 RELATED ID: 1HEG RELATED DB: PDB REMARK 900 HIV-1 PROTEASE COMPLEXED WITH SKF 107457 (HEG) REMARK 900 RELATED ID: 1HIH RELATED DB: PDB REMARK 900 HIV-1 PROTEASE COMPLEXED WITH INHIBITOR CGP 53820 REMARK 900 RELATED ID: 1HMV RELATED DB: PDB REMARK 900 HIV-1 REVERSE TRANSCRIPTASE REMARK 900 RELATED ID: 1HNI RELATED DB: PDB REMARK 900 HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 REVERSE TRANSCRIPTASE (HIV-1RT) REMARK 900 MUTANT WITH CYS 280 REPLACED BY SER (C280S) REMARK 900 RELATED ID: 1HNV RELATED DB: PDB REMARK 900 HIV-1 REVERSE TRANSCRIPTASE (HIV-1 RT) MUTANT WITH CYS 280 REPLACED REMARK 900 BY SER (C280S) REMARK 900 RELATED ID: 1HOS RELATED DB: PDB REMARK 900 HIV-1 PROTEASE COMPLEX WITH SB204144 REMARK 900 RELATED ID: 1HPS RELATED DB: PDB REMARK 900 HIV-1 PROTEASE COMPLEXED WITH SB206343 REMARK 900 RELATED ID: 1HPZ RELATED DB: PDB REMARK 900 HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 REMARK 900 RELATED ID: 1HQE RELATED DB: PDB REMARK 900 HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 REMARK 900 RELATED ID: 1HQU RELATED DB: PDB REMARK 900 HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 REMARK 900 RELATED ID: 1HRH RELATED DB: PDB REMARK 900 RIBONUCLEASE H DOMAIN OF HIV-1 REVERSE TRANSCRIPTASE REMARK 900 RELATED ID: 1HTE RELATED DB: PDB REMARK 900 HIV-1 PROTEASE COMPLEXED WITH GR123976 REMARK 900 RELATED ID: 1HTF RELATED DB: PDB REMARK 900 HIV-1 PROTEASE COMPLEXED WITH GR126045 REMARK 900 RELATED ID: 1HTG RELATED DB: PDB REMARK 900 HIV-1 PROTEASE COMPLEXED WITH GR137615 REMARK 900 RELATED ID: 1HVK RELATED DB: PDB REMARK 900 HIV-1 PROTEASE COMPLEXED WITH THE INHIBITOR A76928 (S,S) REMARK 900 RELATED ID: 1HVP RELATED DB: PDB REMARK 900 HIV-1 PROTEASE COMPLEX WITH SUBSTRATE (THEORETICAL MODEL) REMARK 900 RELATED ID: 1HVU RELATED DB: PDB REMARK 900 HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 REVERSE TRANSCRIPTASE COMPLEXED REMARK 900 WITH A 33-BASE NUCLEOTIDE RIBONUCLEIC ACID PSEUDOKNOT REMARK 900 RELATED ID: 1HYS RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEXWITH A REMARK 900 POLYPURINE TRACT RNA:DNA REMARK 900 RELATED ID: 1IKV RELATED DB: PDB REMARK 900 K103N MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITHEFIVARENZ REMARK 900 RELATED ID: 1IKW RELATED DB: PDB REMARK 900 WILD TYPE HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITHEFAVIRENZ REMARK 900 RELATED ID: 1IKX RELATED DB: PDB REMARK 900 K103N MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITHTHE REMARK 900 INHIBITOR PNU142721 REMARK 900 RELATED ID: 1IKY RELATED DB: PDB REMARK 900 HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH THE INHIBITORMSC194 REMARK 900 RELATED ID: 1J5O RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF MET184ILE MUTANT OF HIV -1 REMARK 900 REVERSETRANSCRIPTASE IN COMPLEX WITH DOUBLE STRANDED DNA TEMPLATE- REMARK 900 PRIMER REMARK 900 RELATED ID: 1MER RELATED DB: PDB REMARK 900 HIV-1 MUTANT (I84V) PROTEASE COMPLEXED WITH DMP450 REMARK 900 RELATED ID: 1MES RELATED DB: PDB REMARK 900 HIV-1 MUTANT (I84V) PROTEASE COMPLEXED WITH DMP323 REMARK 900 RELATED ID: 1MET RELATED DB: PDB REMARK 900 HIV-1 MUTANT (V82F) PROTEASE COMPLEXED WITH DMP323 REMARK 900 RELATED ID: 1MEU RELATED DB: PDB REMARK 900 HIV-1 MUTANT (V82F, I84V) PROTEASE COMPLEXED WITH DMP323 REMARK 900 RELATED ID: 1N5Y RELATED DB: PDB REMARK 900 HIV-1 REVERSE TRANSCRIPTASE CROSSLINKED TO POST-TRANSLOCATION AZTMP- REMARK 900 TERMINATED DNA (COMPLEX P) REMARK 900 RELATED ID: 1N6Q RELATED DB: PDB REMARK 900 HIV-1 REVERSE TRANSCRIPTASE CROSSLINKED TO PRE-TRANSLOCATION AZTMP- REMARK 900 TERMINATED DNA (COMPLEX N) REMARK 900 RELATED ID: 1QE1 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF 3TC-RESISTANT M184I MUTANT OF HIV-1 REVERSE REMARK 900 TRANSCRIPTASE REMARK 900 RELATED ID: 1QMC RELATED DB: PDB REMARK 900 C-TERMINAL DNA-BINDING DOMAIN OF HIV-1 INTEGRASE, NMR, 42 STRUCTURES REMARK 900 RELATED ID: 1R0A RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE COVALENTLYTETHERED REMARK 900 TO DNA TEMPLATE -PRIMER SOLVED TO 2.8 ANGSTROMS REMARK 900 RELATED ID: 1RDH RELATED DB: PDB REMARK 900 HIV-1 REVERSE TRANSCRIPTASE (RIBONUCLEASE H DOMAIN) REMARK 900 RELATED ID: 1RTD RELATED DB: PDB REMARK 900 STRUCTURE OF A CATALYTIC COMPLEX OF HIV-1 REVERSE TRANSCRIPTASE: REMARK 900 IMPLICATIONS FOR NUCLEOSIDE ANALOG DRUG RESISTANCE REMARK 900 RELATED ID: 1RVL RELATED DB: PDB REMARK 900 REVERSE TRANSCRIPTASE NON-NUCLEOSIDE BINDING SITE COMPLEXED WITH REMARK 900 ALPHA-APA (R89439) (THEORETICAL MODEL) REMARK 900 RELATED ID: 1RVM RELATED DB: PDB REMARK 900 REVERSE TRANSCRIPTASE NON-NUCLEOSIDE BINDING SITE COMPLEXED WITH REMARK 900 HEPT (THEORETICAL MODEL) REMARK 900 RELATED ID: 1RVN RELATED DB: PDB REMARK 900 REVERSE TRANSCRIPTASE NON-NUCLEOSIDE BINDING SITE COMPLEXED WITH REMARK 900 PHENYL-ISOINDOLINONE (THEORETICAL MODEL) REMARK 900 RELATED ID: 1RVO RELATED DB: PDB REMARK 900 REVERSE TRANSCRIPTASE NON-NUCLEOSIDE BINDING SITE COMPLEXED WITH REMARK 900 NEVIRAPINE (THEORETICAL MODEL) REMARK 900 RELATED ID: 1RVP RELATED DB: PDB REMARK 900 REVERSE TRANSCRIPTASE NON-NUCLEOSIDE BINDING SITE COMPLEXED WITH REMARK 900 THIAZOLOISOINDOLINONE (THEORETICAL MODEL) REMARK 900 RELATED ID: 1RVQ RELATED DB: PDB REMARK 900 REVERSE TRANSCRIPTASE NON-NUCLEOSIDE BINDING SITE COMPLEXED WITH REMARK 900 TIBO (THEORETICAL MODEL) REMARK 900 RELATED ID: 1RVR RELATED DB: PDB REMARK 900 REVERSE TRANSCRIPTASE NON-NUCLEOSIDE BINDING SITE COMPLEXED WITH REMARK 900 IMIDAZODIPYRIDODIAZEPINE (UK -129,485) (THEORETICAL MODEL) REMARK 900 RELATED ID: 1S6P RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN IMMUNODEFICIENCY VIRUS TYPE 1REVERSE REMARK 900 TRANSCRIPTASE (RT) IN COMPLEX WITH JANSSEN-R100943 REMARK 900 RELATED ID: 1S6Q RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) INCOMPLEX REMARK 900 WITH JANSSEN- R147681 REMARK 900 RELATED ID: 1S9E RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) INCOMPLEX REMARK 900 WITH JANSSEN- R129385 REMARK 900 RELATED ID: 1S9G RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) INCOMPLEX REMARK 900 WITH JANSSEN- R120394. REMARK 900 RELATED ID: 1SBG RELATED DB: PDB REMARK 900 HIV-1 PROTEASE COMPLEXED WITH THE INHIBITOR SB203386 REMARK 900 RELATED ID: 1SUQ RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) INCOMPLEX REMARK 900 WITH JANSSEN- R185545 REMARK 900 RELATED ID: 1SV5 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF K103N MUTANT HIV-1 REVERSETRANSCRIPTASE (RT) REMARK 900 IN COMPLEX WITH JANSSEN-R165335 REMARK 900 RELATED ID: 1T03 RELATED DB: PDB REMARK 900 HIV-1 REVERSE TRANSCRIPTASE CROSSLINKED TO TENOFOVIRTERMINATED REMARK 900 TEMPLATE-PRIMER (COMPLEX P) REMARK 900 RELATED ID: 1T05 RELATED DB: PDB REMARK 900 HIV-1 REVERSE TRANSCRIPTASE CROSSLINKED TO TEMPLATE-PRIMERWITH REMARK 900 TENOFOVIR-DIPHOSPHATE BOUND AS THE INCOMINGNUCLEOTIDE SUBSTRATE REMARK 900 RELATED ID: 1TV6 RELATED DB: PDB REMARK 900 HIV-1 REVERSE TRANSCRIPTASE COMPLEXED WITH CP-94,707 REMARK 900 RELATED ID: 1TVR RELATED DB: PDB REMARK 900 HIV-1 RT/9-CL TIBO REMARK 900 RELATED ID: 1UWB RELATED DB: PDB REMARK 900 TYR 181 CYS HIV-1 RT/8-CL TIBO REMARK 900 RELATED ID: 2HMI RELATED DB: PDB REMARK 900 HIV-1 REVERSE TRANSCRIPTASE COMPLEXED WITH A DOUBLE-STRANDED REMARK 900 DEOXYRIBONUCLEIC ACID AND FAB28 REMARK 900 RELATED ID: 3HVT RELATED DB: PDB REMARK 900 REVERSE TRANSCRIPTASE REMARK 900 RELATED ID: 3TLH RELATED DB: PDB REMARK 900 STRUCTURAL STUDIES OF HIV AND FIV PROTEASES COMPLEXED WITH AN REMARK 900 EFFICIENT INHIBITOR OF FIV PR DBREF 1W5V A -10 99 UNP P03366 POL_HV1B1 58 167 DBREF 1W5V B -10 99 UNP P03366 POL_HV1B1 58 167 SEQRES 1 A 110 ALA ASP ARG GLN GLY THR VAL SER PHE ASN PHE PRO GLN SEQRES 2 A 110 ILE THR LEU TRP GLN ARG PRO LEU VAL THR ILE LYS ILE SEQRES 3 A 110 GLY GLY GLN LEU LYS GLU ALA LEU LEU ASP THR GLY ALA SEQRES 4 A 110 ASP ASP THR VAL LEU GLU GLU MET SER LEU PRO GLY ARG SEQRES 5 A 110 TRP LYS PRO LYS MET ILE GLY GLY ILE GLY GLY PHE ILE SEQRES 6 A 110 LYS VAL ARG GLN TYR ASP GLN ILE LEU ILE GLU ILE CYS SEQRES 7 A 110 GLY HIS LYS ALA ILE GLY THR VAL LEU VAL GLY PRO THR SEQRES 8 A 110 PRO VAL ASN ILE ILE GLY ARG ASN LEU LEU THR GLN ILE SEQRES 9 A 110 GLY CYS THR LEU ASN PHE SEQRES 1 B 110 ALA ASP ARG GLN GLY THR VAL SER PHE ASN PHE PRO GLN SEQRES 2 B 110 ILE THR LEU TRP GLN ARG PRO LEU VAL THR ILE LYS ILE SEQRES 3 B 110 GLY GLY GLN LEU LYS GLU ALA LEU LEU ASP THR GLY ALA SEQRES 4 B 110 ASP ASP THR VAL LEU GLU GLU MET SER LEU PRO GLY ARG SEQRES 5 B 110 TRP LYS PRO LYS MET ILE GLY GLY ILE GLY GLY PHE ILE SEQRES 6 B 110 LYS VAL ARG GLN TYR ASP GLN ILE LEU ILE GLU ILE CYS SEQRES 7 B 110 GLY HIS LYS ALA ILE GLY THR VAL LEU VAL GLY PRO THR SEQRES 8 B 110 PRO VAL ASN ILE ILE GLY ARG ASN LEU LEU THR GLN ILE SEQRES 9 B 110 GLY CYS THR LEU ASN PHE HET BE3 A1100 50 HETNAM BE3 N,N-[2,5-O-DI-3-FLUORO-BENZYL-GLUCARYL]-DI-[1-AMINO- HETNAM 2 BE3 INDAN-2-OL] HETSYN BE3 INHIBITOR BEA403 FORMUL 3 BE3 C38 H38 F2 N2 O8 FORMUL 4 HOH *118(H2 O) HELIX 1 1 GLY A 86 THR A 91 1 6 HELIX 2 2 GLN A 92 GLY A 94 5 3 HELIX 3 3 GLY B 86 THR B 91 1 6 SHEET 1 AA 4 GLN A 2 ILE A 3 0 SHEET 2 AA 4 THR B 96 ASN B 98 -1 O LEU B 97 N ILE A 3 SHEET 3 AA 4 THR A 96 ASN A 98 -1 O THR A 96 N ASN B 98 SHEET 4 AA 4 GLN B 2 ILE B 3 -1 O ILE B 3 N LEU A 97 SHEET 1 AB 8 LEU A 10 ILE A 15 0 SHEET 2 AB 8 GLN A 18 LEU A 24 -1 O GLN A 18 N ILE A 15 SHEET 3 AB 8 ILE A 84 ILE A 85 1 N ILE A 85 O LEU A 23 SHEET 4 AB 8 VAL A 32 LEU A 33 -1 O VAL A 32 N ILE A 84 SHEET 5 AB 8 HIS A 69 VAL A 77 1 O LEU A 76 N LEU A 33 SHEET 6 AB 8 GLY A 52 ILE A 66 -1 O ARG A 57 N VAL A 77 SHEET 7 AB 8 LEU A 10 ILE A 15 -1 O LYS A 14 N GLU A 65 SHEET 8 AB 8 LEU A 10 ILE A 15 0 SHEET 1 BA 8 LEU B 10 ILE B 15 0 SHEET 2 BA 8 GLN B 18 LEU B 24 -1 O GLN B 18 N ILE B 15 SHEET 3 BA 8 ILE B 84 ILE B 85 1 N ILE B 85 O LEU B 23 SHEET 4 BA 8 VAL B 32 LEU B 33 -1 O VAL B 32 N ILE B 84 SHEET 5 BA 8 HIS B 69 VAL B 77 1 O LEU B 76 N LEU B 33 SHEET 6 BA 8 GLY B 52 ILE B 66 -1 O ARG B 57 N VAL B 77 SHEET 7 BA 8 LEU B 10 ILE B 15 -1 O LYS B 14 N GLU B 65 SHEET 8 BA 8 LEU B 10 ILE B 15 0 SITE 1 AC1 29 ARG A 8 LEU A 23 ASP A 25 GLY A 27 SITE 2 AC1 29 ALA A 28 ASP A 29 ASP A 30 VAL A 32 SITE 3 AC1 29 GLY A 48 GLY A 49 ILE A 50 PRO A 81 SITE 4 AC1 29 VAL A 82 ILE A 84 HOH A2030 HOH A2056 SITE 5 AC1 29 ARG B 8 LEU B 23 ASP B 25 GLY B 27 SITE 6 AC1 29 ALA B 28 ASP B 29 ASP B 30 VAL B 32 SITE 7 AC1 29 GLY B 48 GLY B 49 PRO B 81 VAL B 82 SITE 8 AC1 29 ILE B 84 CRYST1 58.532 86.121 46.636 90.00 90.00 90.00 P 21 21 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.017085 0.000000 0.000000 0.00000 SCALE2 0.000000 0.011612 0.000000 0.00000 SCALE3 0.000000 0.000000 0.021443 0.00000